--- a
+++ b/clusters/9knumclustersv2/clust_1343.txt
@@ -0,0 +1,21 @@
+Histologically confirmed diagnosis of secretory multiple myeloma (must have measurable M protein in serum or urine) with at least one of the following:
+Histologically or cytologically confirmed malignant secretory or non-secretory pheochromocytoma or paraganglioma that is unresectable and deemed inappropriate for alternative local regional therapeutic approaches
+Non-secretory or hyposecretory multiple myeloma, prior to initial treatment defined as < . g/dL M-protein in serum, <  mg/ hr urine M-protein, and no measurable disease as per IMWG by Freelite
+Non-secretory multiple myeloma
+Multiple myeloma: stage II or III, symptomatic, secretory multiple myeloma requiring treatment
+Participants with non-secretory or oligo-secretory myeloma, plasma cell leukemia or Waldenstrm's macroglobulinemia
+Non-secretory multiple myeloma
+Multiple myeloma: stage II or III, symptomatic, secretory multiple myeloma requiring treatment
+Patients with non-secretory multiple myeloma are not eligible
+Symptomatic, previously untreated (with exception of corticosteroids) secretory myeloma
+Diagnosis of non-secretory myeloma
+Has non-secretory multiple myeloma
+Non-secretory or oligo-secretory MM
+Has non-secretory or oligosecretory multiple myeloma
+Confirmed diagnosis of symptomatic multiple myeloma and measurable secretory disease
+Non-secretory multiple myeloma.
+Non-secretory or oligo-secretory Multiple Myeloma (Phase II only; such disease is permissible in Phase I).
+Subjects with non-secretory or oligo-secretory or serum free light-chain only myeloma
+Multiple myeloma: stage II or III, symptomatic, secretory multiple myeloma requiring treatment
+Patients with non-secretory or hyposecretory MM
+Multiple myeloma that does not express M-protein or FLC (i.e., non-secretory MM is excluded), and quantitative immunoglobulin levels cannot be used instead.